The company has validated its first product and is now seeking capital to scale-up the aesthetic business and expand into the woundcare market. Within five years the company expects to launch products into markets worth more than £18B with annual revenue of over £300M. With the ability to tap multiple high value global markets with its platform technology the company will be well positioned for either an IPO or acquisition by strategic partners.